当前位置:
X-MOL 学术
›
Curr. Diab. Rep.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Euglycemic Ketoacidosis.
Current Diabetes Reports ( IF 5.2 ) Pub Date : 2020-05-19 , DOI: 10.1007/s11892-020-01307-x Benedetta Maria Bonora 1 , Angelo Avogaro 1 , Gian Paolo Fadini 1
中文翻译:
正常血糖酮症酸中毒。
更新日期:2020-05-19
Current Diabetes Reports ( IF 5.2 ) Pub Date : 2020-05-19 , DOI: 10.1007/s11892-020-01307-x Benedetta Maria Bonora 1 , Angelo Avogaro 1 , Gian Paolo Fadini 1
Affiliation
Purpose of Review
Diabetic ketoacidosis is a life-threatening complication of diabetes characterized by hyperglycemia, acidosis, and ketosis. Ketoacidosis may occur with blood glucose level < 200 mg/dl (improperly defined as euglycemic ketoacidosis, euKA) and also in people without diabetes. The absence of marked hyperglycemia can delay diagnosis and treatment, resulting in potential serious adverse outcomes.Recent Findings
Recently, with the wide clinical use of sodium glucose co-transporter 2 inhibitors (SGLT2i), euKA has come back into the spotlight. Use of SGLT2i use can predispose to the development of ketoacidosis with relatively low or normal levels of blood glucose. This condition, however, can occur, in the absence of diabetes, in settings such as pregnancy, restriction on caloric intake, glycogen storage diseases or defective gluconeogenesis (alcohol abuse or chronic liver disease), and cocaine abuse.Summary
euKA is a challenging diagnosis for most physicians who may be misled by the presence of normal glycemia or mild hyperglycemia. In this article, we review pathophysiology, etiologies, clinical presentation and the management of euKA.中文翻译:
正常血糖酮症酸中毒。